Results 81 to 90 of about 13,503 (207)
Clinical and Experimental Gastroenterology, 2015 Satohiro Matsumoto, Yukio Yoshida Department of Gastroenterology, Saitama Medical Center, Jichi Medical University, Saitama, Japan Background: We conducted a retrospective cohort study to clinically and endoscopically assess the efficacy of delayed ...
Matsumoto S, Yoshida Y
doaj
Mucocele of the appendix: An unusual cause of lower abdominal pain in a patient with ulcerative colitis [PDF]
, 2005 The authors report the case of a 60-year-old male patient. In November 2001 he developed intestinal symptoms of bloody diarrhea and abdominal pain. Colononoscopy and biopsy established the diagnosis of ulcerative colitis (proctosigmoiditis).
Fuszek, Péter +7 more
core
Pharmacoepidemiology and Drug Safety, Volume 35, Issue 4, April 2026.ABSTRACT Immunocompromised individuals experience an impaired immune function due to conditions that might be either congenital or acquired over the course of their lives. Epidemiological studies often rely on clinical definitions which, in some cases, benefit from being translated into machine‐readable algorithms for application to electronic health ...
Judit Riera‐Arnau +62 more
wiley +1 more source
Arquivos de Gastroenterologia, 2013 Context Irritable bowel syndrome (IBS) is a functional bowel disease characterized by abdominal pain and altered intestinal habits. The pathophysiology of IBS remains unclear.
Mauro BAFUTTO +5 more
doaj +1 more source
Difficulties in Making Diagnosis of Inflammatory Bowel Disease: Several Cases Analysis [PDF]
, 2004 Inflammatory bowel disease (IBD) is rarely found in clinical practice. However, the incidence of IBD seems to have increased recently. Generally, the patients will come to hospital with chief complaint of chronic diarrhea with or without hematochezia. We
Hardjodisastro, D. (Daldiyono) +1 more
core +1 more source
Liver International, Volume 46, Issue 4, April 2026.ABSTRACT Background & Aims The distinction of drug‐induced liver injury (DILI), drug‐induced autoimmune‐like hepatitis (DI‐ALH), and autoimmune hepatitis (AIH) can be challenging due to overlapping clinical characteristics. Recently, polyreactive immunoglobulin G (pIgG) was identified as a novel biomarker in AIH.
Theresa Kirchner +18 more
wiley +1 more source
Therapeutics and Clinical Risk Management, 2016 Yunjian Zhang,1 Ling Luo,1 Xiaofang Wang,1 Xiaoyang Liu,1 Xiaoyan Wang,1 Yi Ding2 1Division of Pulmonary and Critical Care Medicine, Department of Medicine, 2Department of Pathology, Jishuitan Hospital, Fourth Medical College of Peking University ...
Zhang Y +5 more
doaj
An Evil Backstage Manipulator: Psychological Factors Correlated with Health-Related Quality of Life in Chinese Patients with Crohn's Disease [PDF]
, 2013 Health-related quality of life (HRQoL) is recommended as one of essential parameters to evaluate treatment effect and clinical outcome in patients with Crohn's disease (CD). Recent studies reported that psychological factors might play a role in HRQoL in
Gu, Guosheng +12 more
core +3 more sources
Release of 5-Aminosalicylic Acid (5-ASA) from Mesalamine Formulations at Various pH Levels [PDF]
, 2015 INTRODUCTION: Oral formulations of 5-aminosalicylic acid (5-ASA) for treatment of ulcerative colitis have been developed to minimize absorption prior to the drug reaching the colon.
Adeyinka Abinusawa, Srini Tenjarla
core +1 more source
Frontiers in GastroenterologyMesalazine is an established and recommended first-line treatment for mild-to-moderate ulcerative colitis (UC). For patients with moderately active UC, the choice to use mesalazine or to initiate treatment with an oral corticosteroid or anti-tumor ...
Kristine Paridaens +2 more
doaj +1 more source